Back to TRDA
TCG Crossover Management, LLC → TRDA
TCG Crossover Management, LLC TRDA Position History
Entrada Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$6.7M
Q3 2026
Peak value
$28.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $21.5M |
| Q1 2026 | $28.9M |
| Q2 2026 | $7.8M |
| Q3 2026 | $6.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.7M | 1.06M | — | — |
| Q2 2026 | $7.8M | 1.06M | — | — |
| Q1 2026 | $28.9M | 2.29M | — | — |
| Q4 2025 | $21.5M | 2.09M | — | — |
Other funds holding TRDA
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC